Bryan Bergman
Concepts (463)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 56 | 2026 | 1247 | 8.950 |
Why?
| | Muscle, Skeletal | 44 | 2026 | 1795 | 6.370 |
Why?
| | Adipose Tissue | 19 | 2026 | 641 | 4.050 |
Why?
| | Exercise | 18 | 2026 | 2206 | 3.200 |
Why?
| | Obesity | 38 | 2026 | 3123 | 3.140 |
Why?
| | Triglycerides | 18 | 2026 | 527 | 3.130 |
Why?
| | Weight Loss | 7 | 2026 | 857 | 2.680 |
Why?
| | Sphingolipids | 8 | 2024 | 83 | 2.640 |
Why?
| | Diabetes Mellitus, Type 2 | 23 | 2024 | 2623 | 2.610 |
Why?
| | Diglycerides | 10 | 2026 | 66 | 2.490 |
Why?
| | Lipid Metabolism | 15 | 2026 | 533 | 2.400 |
Why?
| | Insulin | 28 | 2025 | 2524 | 2.150 |
Why?
| | Liver | 14 | 2026 | 1859 | 1.660 |
Why?
| | Physical Endurance | 13 | 2025 | 278 | 1.570 |
Why?
| | Fasting | 7 | 2025 | 280 | 1.560 |
Why?
| | Blood Glucose | 29 | 2025 | 2357 | 1.540 |
Why?
| | Ceramides | 8 | 2025 | 114 | 1.380 |
Why?
| | Glucose Clamp Technique | 22 | 2025 | 199 | 1.380 |
Why?
| | Lipids | 5 | 2024 | 715 | 1.350 |
Why?
| | Phosphatidylcholines | 2 | 2024 | 130 | 1.240 |
Why?
| | Sarcolemma | 3 | 2024 | 33 | 1.140 |
Why?
| | Rest | 6 | 2017 | 126 | 1.100 |
Why?
| | Paracrine Communication | 2 | 2025 | 67 | 1.030 |
Why?
| | Muscle Fibers, Skeletal | 5 | 2024 | 214 | 1.020 |
Why?
| | Lipogenesis | 4 | 2017 | 62 | 1.010 |
Why?
| | Fatty Acids, Nonesterified | 10 | 2022 | 154 | 0.960 |
Why?
| | Intra-Abdominal Fat | 4 | 2022 | 101 | 0.870 |
Why?
| | Prediabetic State | 5 | 2016 | 250 | 0.870 |
Why?
| | Glucose | 10 | 2025 | 1051 | 0.860 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2023 | 7 | 0.800 |
Why?
| | Glucose Tolerance Test | 11 | 2021 | 360 | 0.790 |
Why?
| | Glucagon-Like Peptide 1 | 2 | 2023 | 150 | 0.790 |
Why?
| | Adult | 49 | 2026 | 40821 | 0.770 |
Why?
| | Pancreas | 1 | 2025 | 342 | 0.740 |
Why?
| | Dietary Fats | 6 | 2020 | 307 | 0.730 |
Why?
| | Subcutaneous Fat | 4 | 2025 | 79 | 0.730 |
Why?
| | Male | 72 | 2026 | 73014 | 0.720 |
Why?
| | Carnitine | 3 | 2024 | 91 | 0.720 |
Why?
| | Tandem Mass Spectrometry | 4 | 2024 | 574 | 0.720 |
Why?
| | Humans | 94 | 2026 | 145625 | 0.700 |
Why?
| | Female | 69 | 2026 | 79080 | 0.670 |
Why?
| | Diabetes Mellitus, Type 1 | 18 | 2019 | 3930 | 0.660 |
Why?
| | Mitochondria, Muscle | 6 | 2026 | 125 | 0.650 |
Why?
| | Athletes | 7 | 2024 | 430 | 0.630 |
Why?
| | Middle Aged | 33 | 2026 | 36359 | 0.590 |
Why?
| | Fatty Liver | 4 | 2026 | 251 | 0.570 |
Why?
| | Energy Metabolism | 5 | 2025 | 930 | 0.570 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1429 | 0.560 |
Why?
| | Phosphatidylethanolamines | 3 | 2026 | 78 | 0.550 |
Why?
| | Glucose Intolerance | 4 | 2014 | 142 | 0.520 |
Why?
| | Lactic Acid | 7 | 2009 | 295 | 0.510 |
Why?
| | Oxidation-Reduction | 8 | 2024 | 1075 | 0.500 |
Why?
| | Adipocytes | 2 | 2023 | 223 | 0.500 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 588 | 0.490 |
Why?
| | Hypoglycemic Agents | 2 | 2023 | 1411 | 0.470 |
Why?
| | Choristoma | 1 | 2015 | 20 | 0.460 |
Why?
| | Endoplasmic Reticulum | 3 | 2026 | 268 | 0.460 |
Why?
| | Body Composition | 10 | 2025 | 686 | 0.450 |
Why?
| | Diet, Western | 5 | 2026 | 88 | 0.410 |
Why?
| | Smoking | 2 | 2012 | 1478 | 0.400 |
Why?
| | Fatty Acids | 6 | 2026 | 460 | 0.400 |
Why?
| | Myocardium | 2 | 2009 | 948 | 0.390 |
Why?
| | Hyperglycemia | 3 | 2014 | 381 | 0.380 |
Why?
| | Benzhydryl Compounds | 1 | 2013 | 81 | 0.370 |
Why?
| | Phenols | 1 | 2013 | 106 | 0.370 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2012 | 55 | 0.370 |
Why?
| | Atrial Function | 2 | 2009 | 10 | 0.360 |
Why?
| | Culture Media, Conditioned | 2 | 2022 | 112 | 0.360 |
Why?
| | Adiposity | 5 | 2024 | 531 | 0.360 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 5875 | 0.360 |
Why?
| | Body Mass Index | 7 | 2025 | 2446 | 0.360 |
Why?
| | Resistance Training | 2 | 2025 | 185 | 0.350 |
Why?
| | Islets of Langerhans | 6 | 2025 | 852 | 0.350 |
Why?
| | Lipoprotein Lipase | 2 | 2015 | 55 | 0.350 |
Why?
| | Homeostasis | 1 | 2016 | 646 | 0.350 |
Why?
| | Hyperinsulinism | 3 | 2024 | 115 | 0.340 |
Why?
| | Physical Fitness | 4 | 2004 | 207 | 0.340 |
Why?
| | Animals | 31 | 2026 | 38030 | 0.340 |
Why?
| | Glycerol | 5 | 2015 | 90 | 0.330 |
Why?
| | Incretins | 1 | 2010 | 21 | 0.320 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2010 | 46 | 0.310 |
Why?
| | Sex Characteristics | 5 | 2024 | 798 | 0.310 |
Why?
| | Sleep Deprivation | 3 | 2021 | 207 | 0.300 |
Why?
| | Pyrazines | 1 | 2010 | 94 | 0.300 |
Why?
| | Sleep | 3 | 2021 | 896 | 0.290 |
Why?
| | Physical Education and Training | 2 | 1999 | 70 | 0.290 |
Why?
| | Triazoles | 1 | 2010 | 190 | 0.280 |
Why?
| | Rats | 6 | 2024 | 5574 | 0.280 |
Why?
| | Cytosol | 2 | 2020 | 215 | 0.280 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2009 | 83 | 0.280 |
Why?
| | Insulin-Secreting Cells | 2 | 2010 | 393 | 0.280 |
Why?
| | Thinness | 2 | 2007 | 99 | 0.260 |
Why?
| | Energy Intake | 4 | 2025 | 506 | 0.250 |
Why?
| | Pulmonary Gas Exchange | 3 | 2007 | 117 | 0.240 |
Why?
| | T-Lymphocytes | 5 | 2000 | 2007 | 0.230 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 178 | 0.230 |
Why?
| | Young Adult | 13 | 2024 | 14240 | 0.220 |
Why?
| | Palmitates | 2 | 2018 | 21 | 0.220 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2019 | 190 | 0.220 |
Why?
| | Heart Rate | 1 | 2008 | 844 | 0.210 |
Why?
| | Body Weight | 2 | 2025 | 964 | 0.210 |
Why?
| | Prostatic Neoplasms | 3 | 2020 | 972 | 0.200 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 43 | 0.200 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 58 | 0.200 |
Why?
| | Catecholamines | 1 | 2023 | 88 | 0.190 |
Why?
| | Caloric Restriction | 1 | 2025 | 133 | 0.190 |
Why?
| | Mice, Inbred NOD | 5 | 2015 | 598 | 0.190 |
Why?
| | Circadian Clocks | 1 | 2023 | 59 | 0.190 |
Why?
| | Adiponectin | 3 | 2015 | 243 | 0.190 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2017 | 456 | 0.190 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.190 |
Why?
| | Mitochondrial Diseases | 1 | 2023 | 94 | 0.190 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 22 | 0.190 |
Why?
| | Ribonucleoside Diphosphate Reductase | 1 | 2022 | 6 | 0.180 |
Why?
| | Gluconeogenesis | 2 | 2018 | 81 | 0.180 |
Why?
| | Oxygen Consumption | 4 | 2016 | 719 | 0.180 |
Why?
| | Blotting, Western | 3 | 2016 | 1176 | 0.180 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 83 | 0.180 |
Why?
| | Adipokines | 1 | 2022 | 56 | 0.180 |
Why?
| | Biopsy | 3 | 2018 | 1073 | 0.180 |
Why?
| | Dinoprostone | 1 | 2022 | 179 | 0.180 |
Why?
| | Histone Deacetylases | 1 | 2023 | 208 | 0.180 |
Why?
| | Subcellular Fractions | 2 | 2021 | 73 | 0.180 |
Why?
| | Phospholipids | 4 | 2026 | 215 | 0.170 |
Why?
| | Vasodilation | 1 | 2025 | 519 | 0.170 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2023 | 218 | 0.170 |
Why?
| | Metabolic Syndrome | 3 | 2026 | 364 | 0.170 |
Why?
| | Physical Conditioning, Animal | 1 | 2024 | 242 | 0.170 |
Why?
| | Case-Control Studies | 5 | 2019 | 3633 | 0.170 |
Why?
| | Interleukin-13 | 1 | 2022 | 149 | 0.170 |
Why?
| | Indoles | 1 | 2025 | 509 | 0.170 |
Why?
| | Stearoyl-CoA Desaturase | 3 | 2012 | 66 | 0.170 |
Why?
| | Interleukin-8 | 1 | 2022 | 268 | 0.170 |
Why?
| | Bone Marrow | 1 | 2023 | 308 | 0.170 |
Why?
| | Dietary Supplements | 1 | 2025 | 586 | 0.170 |
Why?
| | Exercise Test | 5 | 2015 | 634 | 0.170 |
Why?
| | Lipolysis | 2 | 2018 | 44 | 0.170 |
Why?
| | Stem Cells | 1 | 2025 | 612 | 0.160 |
Why?
| | Bone Remodeling | 1 | 2021 | 71 | 0.160 |
Why?
| | Mice | 16 | 2026 | 18266 | 0.160 |
Why?
| | Phosphorylation | 5 | 2025 | 1717 | 0.160 |
Why?
| | Diabetic Angiopathies | 3 | 2011 | 265 | 0.160 |
Why?
| | Knee | 1 | 2001 | 73 | 0.160 |
Why?
| | Immunity | 1 | 2020 | 140 | 0.150 |
Why?
| | Antigens, Surface | 1 | 2000 | 155 | 0.150 |
Why?
| | Electric Stimulation | 1 | 2001 | 271 | 0.150 |
Why?
| | Diabetic Neuropathies | 1 | 2021 | 100 | 0.150 |
Why?
| | Autophagy-Related Proteins | 2 | 2017 | 46 | 0.150 |
Why?
| | Palmitic Acid | 2 | 2010 | 40 | 0.150 |
Why?
| | Hematopoietic Stem Cells | 1 | 2023 | 432 | 0.150 |
Why?
| | Autoantigens | 2 | 2000 | 426 | 0.140 |
Why?
| | Calorimetry, Indirect | 3 | 2019 | 72 | 0.140 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2018 | 37 | 0.140 |
Why?
| | Guanosine Triphosphate | 1 | 2018 | 88 | 0.140 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2018 | 56 | 0.140 |
Why?
| | Kinetics | 6 | 2006 | 1553 | 0.140 |
Why?
| | Pregnancy | 8 | 2025 | 7217 | 0.140 |
Why?
| | Obesity, Abdominal | 1 | 2018 | 48 | 0.140 |
Why?
| | Primary Cell Culture | 1 | 2019 | 172 | 0.140 |
Why?
| | Interleukin-6 | 1 | 2022 | 782 | 0.140 |
Why?
| | Absorptiometry, Photon | 4 | 2025 | 276 | 0.130 |
Why?
| | Muscle Contraction | 1 | 2001 | 427 | 0.130 |
Why?
| | Basal Metabolism | 2 | 2008 | 58 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2018 | 265 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1223 | 0.130 |
Why?
| | Diet | 4 | 2013 | 1271 | 0.130 |
Why?
| | Cell Nucleus | 1 | 2020 | 584 | 0.130 |
Why?
| | Cohort Studies | 5 | 2021 | 6045 | 0.130 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2017 | 6 | 0.130 |
Why?
| | Lung Neoplasms | 2 | 2022 | 2674 | 0.130 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2018 | 125 | 0.120 |
Why?
| | Pediatric Obesity | 1 | 2024 | 635 | 0.120 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2017 | 46 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2025 | 662 | 0.120 |
Why?
| | Extracellular Vesicles | 2 | 2018 | 175 | 0.120 |
Why?
| | Biological Transport | 1 | 2017 | 423 | 0.120 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 441 | 0.120 |
Why?
| | Metabolomics | 3 | 2019 | 737 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2023 | 1790 | 0.110 |
Why?
| | Microtubule-Associated Proteins | 1 | 2017 | 184 | 0.110 |
Why?
| | Phenotype | 1 | 2024 | 3186 | 0.110 |
Why?
| | Metformin | 1 | 2019 | 328 | 0.110 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 97 | 0.110 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 2012 | 55 | 0.110 |
Why?
| | Insulinoma | 2 | 1999 | 30 | 0.110 |
Why?
| | Pain | 1 | 2001 | 787 | 0.110 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1334 | 0.110 |
Why?
| | Weight Gain | 1 | 2019 | 561 | 0.110 |
Why?
| | Amino Acids | 1 | 2019 | 513 | 0.110 |
Why?
| | Biomarkers | 4 | 2023 | 4329 | 0.110 |
Why?
| | Adolescent | 12 | 2024 | 22451 | 0.110 |
Why?
| | RNA, Messenger | 4 | 2014 | 2783 | 0.100 |
Why?
| | Cell Hypoxia | 1 | 2015 | 247 | 0.100 |
Why?
| | Circadian Rhythm | 1 | 2019 | 514 | 0.100 |
Why?
| | Algorithms | 3 | 2015 | 1843 | 0.100 |
Why?
| | Coronary Artery Disease | 2 | 2011 | 751 | 0.100 |
Why?
| | Venous Thromboembolism | 1 | 2018 | 330 | 0.100 |
Why?
| | Somatostatin | 1 | 2014 | 54 | 0.100 |
Why?
| | Mitochondria | 2 | 2018 | 996 | 0.100 |
Why?
| | Receptors, AMPA | 1 | 2015 | 147 | 0.100 |
Why?
| | Oxygen | 2 | 2015 | 996 | 0.100 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 610 | 0.100 |
Why?
| | Regression Analysis | 1 | 2016 | 994 | 0.100 |
Why?
| | Fetal Development | 1 | 2016 | 296 | 0.100 |
Why?
| | Fructose | 1 | 2014 | 132 | 0.100 |
Why?
| | Cytoplasmic Granules | 1 | 1994 | 73 | 0.100 |
Why?
| | Clone Cells | 4 | 2000 | 259 | 0.100 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1194 | 0.100 |
Why?
| | Neurodegenerative Diseases | 1 | 2015 | 147 | 0.100 |
Why?
| | Leg | 3 | 1999 | 243 | 0.100 |
Why?
| | Mice, Inbred C57BL | 3 | 2026 | 6021 | 0.100 |
Why?
| | Glycogen | 2 | 2025 | 55 | 0.090 |
Why?
| | Antigens, Neoplasm | 2 | 1994 | 271 | 0.090 |
Why?
| | Medroxyprogesterone Acetate | 1 | 2012 | 33 | 0.090 |
Why?
| | Macaca | 3 | 2018 | 66 | 0.090 |
Why?
| | Taxoids | 1 | 2012 | 115 | 0.090 |
Why?
| | Progestins | 1 | 2012 | 67 | 0.090 |
Why?
| | Coronary Vessels | 2 | 2010 | 245 | 0.090 |
Why?
| | Cholesterol | 2 | 2013 | 410 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2591 | 0.090 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2013 | 140 | 0.090 |
Why?
| | Signal Transduction | 5 | 2025 | 5234 | 0.090 |
Why?
| | Myocardial Contraction | 1 | 2013 | 292 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2025 | 438 | 0.080 |
Why?
| | Reference Values | 2 | 2010 | 787 | 0.080 |
Why?
| | Hemodynamics | 3 | 2008 | 1114 | 0.080 |
Why?
| | Fenofibrate | 1 | 2011 | 28 | 0.080 |
Why?
| | Recovery of Function | 1 | 2015 | 721 | 0.080 |
Why?
| | Hypoxia | 1 | 2018 | 1209 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 973 | 0.080 |
Why?
| | Child | 9 | 2024 | 22638 | 0.080 |
Why?
| | Sitagliptin Phosphate | 1 | 2010 | 31 | 0.080 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2097 | 0.080 |
Why?
| | Estradiol | 2 | 2019 | 517 | 0.080 |
Why?
| | Hypolipidemic Agents | 1 | 2011 | 89 | 0.080 |
Why?
| | Cell Line | 5 | 2022 | 2809 | 0.080 |
Why?
| | Nicotine | 1 | 2012 | 334 | 0.080 |
Why?
| | Retinoid X Receptor gamma | 1 | 2009 | 5 | 0.070 |
Why?
| | Metabolic Clearance Rate | 2 | 2006 | 115 | 0.070 |
Why?
| | PPAR alpha | 1 | 2009 | 56 | 0.070 |
Why?
| | C-Peptide | 1 | 2010 | 191 | 0.070 |
Why?
| | Expiratory Reserve Volume | 1 | 2008 | 1 | 0.070 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2012 | 454 | 0.070 |
Why?
| | Bicycling | 1 | 2010 | 117 | 0.070 |
Why?
| | Calcinosis | 1 | 2011 | 231 | 0.070 |
Why?
| | Lipoproteins | 1 | 2010 | 165 | 0.070 |
Why?
| | Gene Expression | 3 | 2023 | 1461 | 0.070 |
Why?
| | Proteins | 3 | 2015 | 1021 | 0.070 |
Why?
| | Coronary Circulation | 1 | 2008 | 134 | 0.070 |
Why?
| | Ethinyl Estradiol | 1 | 1988 | 16 | 0.070 |
Why?
| | Arteries | 2 | 2000 | 260 | 0.070 |
Why?
| | Calcium | 2 | 2010 | 1181 | 0.070 |
Why?
| | Receptor, Insulin | 1 | 2007 | 92 | 0.060 |
Why?
| | Regional Blood Flow | 2 | 1999 | 507 | 0.060 |
Why?
| | Phosphatidylglycerols | 1 | 2026 | 21 | 0.060 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2012 | 889 | 0.060 |
Why?
| | Pancreatic Neoplasms | 2 | 1999 | 944 | 0.060 |
Why?
| | Hyperphagia | 1 | 2006 | 37 | 0.060 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4565 | 0.060 |
Why?
| | Cardiovascular Diseases | 3 | 2018 | 2218 | 0.060 |
Why?
| | Indoleacetic Acids | 1 | 2025 | 10 | 0.060 |
Why?
| | Hepatic Stellate Cells | 1 | 2025 | 14 | 0.060 |
Why?
| | Overweight | 1 | 2011 | 613 | 0.060 |
Why?
| | Heart | 1 | 2009 | 624 | 0.060 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2025 | 27 | 0.060 |
Why?
| | Adaptation, Physiological | 1 | 2010 | 567 | 0.060 |
Why?
| | Substance Withdrawal Syndrome | 1 | 1988 | 184 | 0.060 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2025 | 61 | 0.060 |
Why?
| | GTPase-Activating Proteins | 1 | 2025 | 81 | 0.060 |
Why?
| | Sex Factors | 4 | 2018 | 2101 | 0.060 |
Why?
| | Infant | 3 | 2024 | 10093 | 0.050 |
Why?
| | Sex Hormone-Binding Globulin | 2 | 2019 | 51 | 0.050 |
Why?
| | Glucose-6-Phosphatase | 2 | 2001 | 32 | 0.050 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 17 | 0.050 |
Why?
| | Maternal Exposure | 1 | 2025 | 189 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2004 | 51 | 0.050 |
Why?
| | Uncoupling Protein 1 | 1 | 2023 | 17 | 0.050 |
Why?
| | Adipogenesis | 1 | 2024 | 56 | 0.050 |
Why?
| | Ubiquinone | 1 | 2023 | 36 | 0.050 |
Why?
| | Electron Transport | 1 | 2023 | 110 | 0.050 |
Why?
| | Metabolome | 2 | 2019 | 390 | 0.050 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 73 | 0.050 |
Why?
| | Thermogenesis | 1 | 2023 | 45 | 0.050 |
Why?
| | Carbohydrate Metabolism | 2 | 2004 | 59 | 0.050 |
Why?
| | Adipose Tissue, Brown | 1 | 2023 | 60 | 0.050 |
Why?
| | Physical Exertion | 1 | 2004 | 204 | 0.050 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2024 | 192 | 0.050 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 47 | 0.050 |
Why?
| | Aged | 6 | 2018 | 26251 | 0.050 |
Why?
| | Primates | 1 | 2023 | 133 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2010 | 2910 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2023 | 267 | 0.040 |
Why?
| | Prognosis | 2 | 2023 | 4331 | 0.040 |
Why?
| | Time Factors | 2 | 2010 | 7079 | 0.040 |
Why?
| | Protein Binding | 2 | 2018 | 2239 | 0.040 |
Why?
| | Osteocalcin | 1 | 2021 | 37 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2131 | 0.040 |
Why?
| | Swine, Miniature | 2 | 2013 | 88 | 0.040 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2015 | 198 | 0.040 |
Why?
| | Acute Disease | 1 | 2024 | 1033 | 0.040 |
Why?
| | Muscle Strength | 1 | 2024 | 332 | 0.040 |
Why?
| | Ranolazine | 1 | 2020 | 23 | 0.040 |
Why?
| | Neoplasms | 1 | 2017 | 2944 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2012 | 2218 | 0.040 |
Why?
| | Torque | 1 | 2001 | 82 | 0.040 |
Why?
| | Oxidative Stress | 2 | 2018 | 1367 | 0.040 |
Why?
| | Electrodes | 1 | 2001 | 111 | 0.040 |
Why?
| | Collagen Type I | 1 | 2021 | 144 | 0.040 |
Why?
| | Adenocarcinoma | 1 | 1988 | 927 | 0.040 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2022 | 212 | 0.040 |
Why?
| | Detergents | 1 | 2000 | 42 | 0.040 |
Why?
| | Testosterone | 2 | 2019 | 419 | 0.040 |
Why?
| | Chromatography, Ion Exchange | 1 | 2000 | 57 | 0.040 |
Why?
| | Chromatography, Gel | 1 | 2000 | 131 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2020 | 224 | 0.040 |
Why?
| | Serine | 1 | 2021 | 142 | 0.040 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2000 | 112 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 326 | 0.040 |
Why?
| | Solubility | 1 | 2000 | 240 | 0.040 |
Why?
| | Cell Membrane | 2 | 2000 | 701 | 0.040 |
Why?
| | Tumor Burden | 1 | 2020 | 326 | 0.040 |
Why?
| | Mice, SCID | 1 | 2000 | 360 | 0.040 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2000 | 175 | 0.040 |
Why?
| | Eating | 1 | 2021 | 386 | 0.040 |
Why?
| | Isometric Contraction | 1 | 2001 | 190 | 0.040 |
Why?
| | Glucose Transporter Type 4 | 1 | 2018 | 39 | 0.040 |
Why?
| | Osmolar Concentration | 1 | 1999 | 165 | 0.030 |
Why?
| | Swine | 2 | 2013 | 821 | 0.030 |
Why?
| | Thromboplastin | 1 | 2018 | 67 | 0.030 |
Why?
| | Glucagon | 1 | 1999 | 114 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2024 | 2533 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2000 | 242 | 0.030 |
Why?
| | Postprandial Period | 1 | 1999 | 114 | 0.030 |
Why?
| | Perception | 1 | 2001 | 372 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1878 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2025 | 4112 | 0.030 |
Why?
| | Research Design | 1 | 2024 | 1139 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2020 | 446 | 0.030 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 767 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2020 | 507 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 1999 | 228 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 365 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2023 | 843 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2018 | 777 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2015 | 2497 | 0.030 |
Why?
| | Nutritional Status | 1 | 1999 | 344 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 3538 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2017 | 120 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 728 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2022 | 982 | 0.030 |
Why?
| | Waist Circumference | 1 | 2015 | 142 | 0.030 |
Why?
| | Deuterium | 1 | 2015 | 101 | 0.030 |
Why?
| | Androgens | 1 | 2016 | 179 | 0.030 |
Why?
| | HeLa Cells | 1 | 2017 | 635 | 0.030 |
Why?
| | Lymphocyte Activation | 3 | 1994 | 1136 | 0.030 |
Why?
| | Epitopes | 1 | 1997 | 479 | 0.030 |
Why?
| | Protein Subunits | 1 | 2015 | 225 | 0.030 |
Why?
| | Prospective Studies | 2 | 2018 | 8087 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2020 | 929 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 2064 | 0.030 |
Why?
| | Autophagy | 1 | 2017 | 290 | 0.030 |
Why?
| | Centrifugation, Density Gradient | 1 | 1994 | 36 | 0.030 |
Why?
| | Culture Techniques | 1 | 1994 | 65 | 0.030 |
Why?
| | Cell Fractionation | 1 | 1994 | 50 | 0.030 |
Why?
| | Animal Feed | 1 | 2014 | 50 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 503 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2000 | 1130 | 0.020 |
Why?
| | Survival Rate | 1 | 2018 | 2078 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 1997 | 411 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 1994 | 384 | 0.020 |
Why?
| | Acyl Coenzyme A | 1 | 2013 | 32 | 0.020 |
Why?
| | Macrophage Activation | 1 | 2014 | 182 | 0.020 |
Why?
| | Memory | 1 | 2015 | 298 | 0.020 |
Why?
| | Heart Function Tests | 1 | 2013 | 59 | 0.020 |
Why?
| | Gonanes | 1 | 2012 | 23 | 0.020 |
Why?
| | Amyloid beta-Peptides | 1 | 2015 | 251 | 0.020 |
Why?
| | Risk Factors | 3 | 2012 | 10840 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6449 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2852 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2015 | 558 | 0.020 |
Why?
| | Cardiolipins | 1 | 2013 | 83 | 0.020 |
Why?
| | Anaerobic Threshold | 2 | 2004 | 29 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1994 | 878 | 0.020 |
Why?
| | Amino Acid Sequence | 3 | 2001 | 2088 | 0.020 |
Why?
| | Fetus | 1 | 2016 | 798 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 1992 | 161 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2015 | 530 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2015 | 481 | 0.020 |
Why?
| | Incidence | 1 | 2018 | 2910 | 0.020 |
Why?
| | Molecular Weight | 1 | 2012 | 295 | 0.020 |
Why?
| | Abdominal Fat | 1 | 2012 | 50 | 0.020 |
Why?
| | Molecular Sequence Data | 3 | 2001 | 2835 | 0.020 |
Why?
| | Models, Statistical | 1 | 2015 | 667 | 0.020 |
Why?
| | Learning | 1 | 2015 | 446 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2015 | 547 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 306 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 241 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1866 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 2 | 2010 | 2766 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2011 | 201 | 0.020 |
Why?
| | Sex Distribution | 1 | 2010 | 379 | 0.020 |
Why?
| | Abdomen | 1 | 2010 | 140 | 0.020 |
Why?
| | Hippocampus | 1 | 2015 | 986 | 0.020 |
Why?
| | Conserved Sequence | 2 | 2001 | 242 | 0.020 |
Why?
| | Sequence Alignment | 2 | 2001 | 360 | 0.020 |
Why?
| | Cloning, Molecular | 2 | 2001 | 526 | 0.020 |
Why?
| | Child, Preschool | 1 | 2024 | 11888 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 511 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5397 | 0.020 |
Why?
| | Spleen | 1 | 2010 | 503 | 0.020 |
Why?
| | Leydig Cells | 1 | 1988 | 14 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2436 | 0.020 |
Why?
| | Gonadotropins, Pituitary | 1 | 1988 | 21 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2015 | 3121 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2010 | 452 | 0.020 |
Why?
| | Environmental Monitoring | 1 | 2010 | 346 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2009 | 384 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 1992 | 884 | 0.020 |
Why?
| | Base Sequence | 2 | 2001 | 2119 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 2079 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3917 | 0.010 |
Why?
| | Macrophages | 1 | 2014 | 1530 | 0.010 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 448 | 0.010 |
Why?
| | Patient Selection | 1 | 2010 | 720 | 0.010 |
Why?
| | Age Factors | 1 | 2012 | 3321 | 0.010 |
Why?
| | Femoral Vein | 1 | 2004 | 36 | 0.010 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2004 | 124 | 0.010 |
Why?
| | Hormones | 1 | 2004 | 134 | 0.010 |
Why?
| | Alanine | 1 | 2004 | 171 | 0.010 |
Why?
| | Blood Pressure | 1 | 2009 | 1761 | 0.010 |
Why?
| | Femoral Artery | 1 | 2004 | 183 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2915 | 0.010 |
Why?
| | Glycolysis | 1 | 2004 | 341 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2010 | 1101 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2001 | 196 | 0.010 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2000 | 21 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2001 | 234 | 0.010 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 76 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2012 | 2411 | 0.010 |
Why?
| | Isoenzymes | 1 | 2000 | 294 | 0.010 |
Why?
| | Mice, Obese | 1 | 1999 | 68 | 0.010 |
Why?
| | Myosin Heavy Chains | 1 | 2000 | 177 | 0.010 |
Why?
| | Fishes | 1 | 1999 | 111 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 382 | 0.010 |
Why?
| | Open Reading Frames | 1 | 1999 | 130 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 1999 | 357 | 0.010 |
Why?
| | Exons | 1 | 1999 | 361 | 0.010 |
Why?
| | Dogs | 1 | 1999 | 516 | 0.010 |
Why?
| | Alternative Splicing | 1 | 1999 | 249 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2001 | 1236 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1999 | 1244 | 0.010 |
Why?
| | Models, Molecular | 1 | 1999 | 1571 | 0.010 |
Why?
| | Genetic Variation | 1 | 1999 | 992 | 0.010 |
Why?
| | Trinitrobenzenes | 1 | 1992 | 14 | 0.010 |
Why?
| | Adenoma, Islet Cell | 1 | 1992 | 6 | 0.010 |
Why?
| | Hybrid Cells | 1 | 1992 | 47 | 0.010 |
Why?
| | Haptens | 1 | 1992 | 25 | 0.010 |
Why?
| | Ovalbumin | 1 | 1992 | 187 | 0.010 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 1992 | 133 | 0.010 |
Why?
| | Interleukin-2 | 1 | 1992 | 434 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 1989 | 290 | 0.000 |
Why?
| | Pituitary Gland | 1 | 1989 | 148 | 0.000 |
Why?
| | Islets of Langerhans Transplantation | 1 | 1989 | 71 | 0.000 |
Why?
|
|
Bergman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|